EDN1 and focal segmental glomerulosclerosis: Increased levels of serum and urinary ET-1 in patients with FSGS and the beneficial effects of ETAR blockers in experimental age-associated FSGS suggest that the endothelin system is involved in the pathogenesis of FSGS as well.15